Retrospective analysis of protein kinase C-beta (PKC-β) expression in lymphoid malignancies and its association with survival in diffuse large B-cell lymphomas
<p>Abstract</p> <p>Background</p> <p>Both mechanistic features and recent correlative findings suggest a potential role for protein kinase C-beta (PKC-β) in tumor pathogenesis, particularly in B-cell malignancies. To evaluate the role of this gene in lymphoid malignanci...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-02-01
|
Series: | Biology Direct |
Online Access: | http://www.biology-direct.com/content/2/1/8 |
_version_ | 1818353727489179648 |
---|---|
author | Lin Boris K Sutton Susan Brail Leslie Lahn Michael Phong Mark Li Shuyu Thornton Donald Liao Birong |
author_facet | Lin Boris K Sutton Susan Brail Leslie Lahn Michael Phong Mark Li Shuyu Thornton Donald Liao Birong |
author_sort | Lin Boris K |
collection | DOAJ |
description | <p>Abstract</p> <p>Background</p> <p>Both mechanistic features and recent correlative findings suggest a potential role for protein kinase C-beta (PKC-β) in tumor pathogenesis, particularly in B-cell malignancies. To evaluate the role of this gene in lymphoid malignancies, we analyzed global gene expression data to quantify PKC-β expression across diagnostic groups and, when possible, determined correlations between PKC-β expression and survival.</p> <p>Results</p> <p>Our analysis showed that the level of PKC-β expression was highest in chronic lymphocytic leukemia and follicular lymphoma. Within diffuse large-B cell lymphoma (DLBCL), PKC-β expression was significantly higher in activated B-cell- like subtype than germinal center B-cell- like subtype (<it>P </it>< 0.0001). Elevated PKC-β appeared to be associated with worse survival in both of these subtypes. When analyzed within clinically defined risk groups established by the International Prognostic Index (IPI), PKC-β expression was lowest in patients with low IPI scores (0–1). Within intermediate- and high-risk IPI groups, elevated PKC-β expression was associated with worse survival, suggesting that PKC-β may expand the prognostic value of the IPI. Results of global gene expression analyses of DLBCL samples corroborate previous observations that anti-apoptosis, cell proliferation, and B-cell proliferation signaling pathways are functionally related to PKC-β.</p> <p>Conclusion</p> <p>We present a first detailed pharmacogenomics report comparing PKC-β mRNA expression across different lymphoid malignancies and evaluating it as an outcome predictor. Our findings suggest that DLBCL patients with elevated PKC-β have a worse prognosis, indicating that further evaluation of PKC-β as a chemotherapeutic target for lymphoid malignancies is warranted.</p> <p>Reviewers</p> <p>This article was reviewed by Dr. Pierre Pontarotti, Dr. Kateryna Makova, and Dr. Matthew Coleman (nominated by Dr. Sandrine Dudoit).</p> |
first_indexed | 2024-12-13T19:14:08Z |
format | Article |
id | doaj.art-d40c5f7b40f74918b42342595baeea27 |
institution | Directory Open Access Journal |
issn | 1745-6150 |
language | English |
last_indexed | 2024-12-13T19:14:08Z |
publishDate | 2007-02-01 |
publisher | BMC |
record_format | Article |
series | Biology Direct |
spelling | doaj.art-d40c5f7b40f74918b42342595baeea272022-12-21T23:34:21ZengBMCBiology Direct1745-61502007-02-0121810.1186/1745-6150-2-8Retrospective analysis of protein kinase C-beta (PKC-β) expression in lymphoid malignancies and its association with survival in diffuse large B-cell lymphomasLin Boris KSutton SusanBrail LeslieLahn MichaelPhong MarkLi ShuyuThornton DonaldLiao Birong<p>Abstract</p> <p>Background</p> <p>Both mechanistic features and recent correlative findings suggest a potential role for protein kinase C-beta (PKC-β) in tumor pathogenesis, particularly in B-cell malignancies. To evaluate the role of this gene in lymphoid malignancies, we analyzed global gene expression data to quantify PKC-β expression across diagnostic groups and, when possible, determined correlations between PKC-β expression and survival.</p> <p>Results</p> <p>Our analysis showed that the level of PKC-β expression was highest in chronic lymphocytic leukemia and follicular lymphoma. Within diffuse large-B cell lymphoma (DLBCL), PKC-β expression was significantly higher in activated B-cell- like subtype than germinal center B-cell- like subtype (<it>P </it>< 0.0001). Elevated PKC-β appeared to be associated with worse survival in both of these subtypes. When analyzed within clinically defined risk groups established by the International Prognostic Index (IPI), PKC-β expression was lowest in patients with low IPI scores (0–1). Within intermediate- and high-risk IPI groups, elevated PKC-β expression was associated with worse survival, suggesting that PKC-β may expand the prognostic value of the IPI. Results of global gene expression analyses of DLBCL samples corroborate previous observations that anti-apoptosis, cell proliferation, and B-cell proliferation signaling pathways are functionally related to PKC-β.</p> <p>Conclusion</p> <p>We present a first detailed pharmacogenomics report comparing PKC-β mRNA expression across different lymphoid malignancies and evaluating it as an outcome predictor. Our findings suggest that DLBCL patients with elevated PKC-β have a worse prognosis, indicating that further evaluation of PKC-β as a chemotherapeutic target for lymphoid malignancies is warranted.</p> <p>Reviewers</p> <p>This article was reviewed by Dr. Pierre Pontarotti, Dr. Kateryna Makova, and Dr. Matthew Coleman (nominated by Dr. Sandrine Dudoit).</p>http://www.biology-direct.com/content/2/1/8 |
spellingShingle | Lin Boris K Sutton Susan Brail Leslie Lahn Michael Phong Mark Li Shuyu Thornton Donald Liao Birong Retrospective analysis of protein kinase C-beta (PKC-β) expression in lymphoid malignancies and its association with survival in diffuse large B-cell lymphomas Biology Direct |
title | Retrospective analysis of protein kinase C-beta (PKC-β) expression in lymphoid malignancies and its association with survival in diffuse large B-cell lymphomas |
title_full | Retrospective analysis of protein kinase C-beta (PKC-β) expression in lymphoid malignancies and its association with survival in diffuse large B-cell lymphomas |
title_fullStr | Retrospective analysis of protein kinase C-beta (PKC-β) expression in lymphoid malignancies and its association with survival in diffuse large B-cell lymphomas |
title_full_unstemmed | Retrospective analysis of protein kinase C-beta (PKC-β) expression in lymphoid malignancies and its association with survival in diffuse large B-cell lymphomas |
title_short | Retrospective analysis of protein kinase C-beta (PKC-β) expression in lymphoid malignancies and its association with survival in diffuse large B-cell lymphomas |
title_sort | retrospective analysis of protein kinase c beta pkc β expression in lymphoid malignancies and its association with survival in diffuse large b cell lymphomas |
url | http://www.biology-direct.com/content/2/1/8 |
work_keys_str_mv | AT linborisk retrospectiveanalysisofproteinkinasecbetapkcbexpressioninlymphoidmalignanciesanditsassociationwithsurvivalindiffuselargebcelllymphomas AT suttonsusan retrospectiveanalysisofproteinkinasecbetapkcbexpressioninlymphoidmalignanciesanditsassociationwithsurvivalindiffuselargebcelllymphomas AT brailleslie retrospectiveanalysisofproteinkinasecbetapkcbexpressioninlymphoidmalignanciesanditsassociationwithsurvivalindiffuselargebcelllymphomas AT lahnmichael retrospectiveanalysisofproteinkinasecbetapkcbexpressioninlymphoidmalignanciesanditsassociationwithsurvivalindiffuselargebcelllymphomas AT phongmark retrospectiveanalysisofproteinkinasecbetapkcbexpressioninlymphoidmalignanciesanditsassociationwithsurvivalindiffuselargebcelllymphomas AT lishuyu retrospectiveanalysisofproteinkinasecbetapkcbexpressioninlymphoidmalignanciesanditsassociationwithsurvivalindiffuselargebcelllymphomas AT thorntondonald retrospectiveanalysisofproteinkinasecbetapkcbexpressioninlymphoidmalignanciesanditsassociationwithsurvivalindiffuselargebcelllymphomas AT liaobirong retrospectiveanalysisofproteinkinasecbetapkcbexpressioninlymphoidmalignanciesanditsassociationwithsurvivalindiffuselargebcelllymphomas |